Drug firm AstraZeneca Pharma India reported a 66.65 percent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018.
The company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE. Company's total revenue for the quarter under consideration stood at Rs 164.71 crore.
It was Rs 166.75 crore for the same period year ago. Shares of AstraZeneca Pharma India today closed at Rs 1,702.60 per scrip on BSE, up 0.70 percent from the previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.